Imidazopyridazine compounds
US10077269B2 · kind B2 · utility
0Cited by
11References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2017 |
| Grant date | Sep 18, 2018 |
| Priority date | — |
| Expiry date | Feb 7, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein the substituents R1, R3, R6, R7, and b are as defined herein. The invention is also directed to pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, and methods of preparing the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.